Cabio Biotech (China) Price on August 27, 2024

688089 Stock   18.28  0.19  1.05%   
Below is the normalized historical share price chart for Cabio Biotech Wuhan extending back to December 19, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cabio Biotech stands at 18.28, as last reported on the 8th of January, with the highest price reaching 18.32 and the lowest price hitting 17.80 during the day.
200 Day MA
16.8014
50 Day MA
21.2046
Beta
0.629
 
Covid
If you're considering investing in Cabio Stock, it is important to understand the factors that can impact its price. Cabio Biotech Wuhan secures Sharpe Ratio (or Efficiency) of -0.008, which signifies that the company had a -0.008% return per unit of standard deviation over the last 3 months. Cabio Biotech Wuhan exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cabio Biotech's mean deviation of 3.3, and Risk Adjusted Performance of 0.0363 to double-check the risk estimate we provide.
  
As of January 8, 2025, Total Stockholder Equity is expected to decline to about 1.1 B. In addition to that, Common Stock Shares Outstanding is expected to decline to about 130.2 M. Cabio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.008

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns688089

Estimated Market Risk

 4.26
  actual daily
37
63% of assets are more volatile

Expected Return

 -0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cabio Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cabio Biotech by adding Cabio Biotech to a well-diversified portfolio.
Price Book
1.9944
Enterprise Value Ebitda
22.4908
Price Sales
6.0124
Shares Float
86.5 M
Wall Street Target Price
17

Cabio Biotech Main Headline on 27th of August 2024

Cabio Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 Marketscreener.com

Cabio Biotech Valuation on August 27, 2024

It is possible to determine the worth of Cabio Biotech on a given historical date. On August 27, 2024 Cabio was worth 14.25 at the beginning of the trading date compared to the closed value of 14.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cabio Biotech stock. Still, in general, we apply an absolute valuation method to find Cabio Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cabio Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cabio Biotech's related companies.
 Open High Low Close Volume
  14.10    14.55    14.10    14.49    1,376,729  
08/27/2024
  14.25    14.76    14.25    14.54    1,690,101  
  14.39    14.97    14.20    14.68    2,277,633  
Backtest Cabio Biotech  |  Cabio Biotech History  |  Cabio Biotech Valuation   PreviousNext  
Open Value
14.25
14.54
Closing Value
27.03
Upside

Cabio Biotech Trading Date Momentum on August 27, 2024

On August 28 2024 Cabio Biotech Wuhan was traded for  14.68  at the closing time. The highest price during the trading period was 14.97  and the lowest recorded bid was listed for  14.20 . The volume for the day was 2.3 M. This history from August 28, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 0.96% . The overall trading delta to the current price is 4.20% .

Cabio Biotech Wuhan Fundamentals Correlations and Trends

By evaluating Cabio Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cabio Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cabio financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cabio Biotech Stock history

Cabio Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cabio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cabio Biotech Wuhan will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cabio Biotech stock prices may prove useful in developing a viable investing in Cabio Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding193.6 M130.2 M
Net Income Applicable To Common Shares57.9 M88.3 M

Cabio Biotech Quarterly Net Working Capital

598.98 Million

Cabio Biotech Stock Technical Analysis

Cabio Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cabio Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cabio Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cabio Biotech Period Price Range

Low
January 8, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Cabio Biotech Wuhan cannot be verified against its exchange. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cabio Biotech January 8, 2025 Market Strength

Market strength indicators help investors to evaluate how Cabio Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cabio Biotech shares will generate the highest return on investment. By undertsting and applying Cabio Biotech stock market strength indicators, traders can identify Cabio Biotech Wuhan entry and exit signals to maximize returns

Cabio Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cabio Biotech's price direction in advance. Along with the technical and fundamental analysis of Cabio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cabio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Cabio Stock analysis

When running Cabio Biotech's price analysis, check to measure Cabio Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabio Biotech is operating at the current time. Most of Cabio Biotech's value examination focuses on studying past and present price action to predict the probability of Cabio Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabio Biotech's price. Additionally, you may evaluate how the addition of Cabio Biotech to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators